Published in N Engl J Med on June 15, 1989
Human immunodeficiency virus seroprevalence in primary care practices in the United States. West J Med (1993) 1.50
Human immunodeficiency virus seropositivity among members of the active duty US Army 1985-89. Am J Public Health (1990) 1.26
Methods of surveillance for HIV infection in primary care outpatients in the United States. Public Health Rep (1990) 1.13
HIV-1 seroconversion and risk behaviors among young men in the US army. The Seroconversion Risk Factor Study Group. Am J Public Health (1995) 0.87
Stalking the HIV epidemic: which tracks to follow and how far? Am J Public Health (1990) 0.80
Decline in human immunodeficiency virus seropositivity and seroconversion in US Navy enlisted personnel: 1986 to 1989. Navy HIV Working Group. Am J Public Health (1992) 0.80
Tuberculin skin testing in US Navy and Marine Corps personnel and recruits, 1980-86. Am J Public Health (1990) 0.78
HIV seroconversion in the U.S. Army. N Engl J Med (1989) 0.75
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21
Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med (1977) 8.24
Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses (1995) 7.12
Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A (2000) 4.75
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med (1991) 4.23
Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis (1977) 3.51
Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44
Detection of diverse HIV-1 genetic subtypes in the USA. Lancet (1995) 3.41
Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr (1990) 2.84
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol (1996) 2.83
Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986. Demographic factors associated with seropositivity. N Engl J Med (1987) 2.81
45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med (2000) 2.66
Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med (1987) 2.59
Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis (1985) 2.59
Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 2.52
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J Infect Dis (1994) 2.42
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38
An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med (1984) 2.32
Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science (1988) 2.31
Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells. J Biol Chem (1993) 2.23
Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. N Engl J Med (1988) 2.22
The nature, incidence, and impact of eye injuries among US military personnel: implications for prevention. Arch Ophthalmol (2001) 2.12
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science (1996) 2.11
Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol (1982) 2.10
False-positive Western blot tests for antibodies to HTLV-III. JAMA (1986) 2.07
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04
The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. J Acquir Immune Defic Syndr (1991) 2.04
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses (1994) 1.90
Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol (1985) 1.73
HIV-1 genetic diversity. AIDS (1996) 1.69
Human immunodeficiency virus infections in teenagers. Seroprevalence among applicants for US military service. The Walter Reed Retrovirus Research Group. JAMA (1990) 1.67
Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA (1993) 1.63
Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination. J Infect Dis (1999) 1.63
Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA (1992) 1.62
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62
Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA (1987) 1.59
Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol (1989) 1.59
Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg (1989) 1.57
Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey. J Infect Dis (1998) 1.48
Prevalence and incidence of HTLV-III infection in a prison. JAMA (1986) 1.48
Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J Virol (1991) 1.48
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay. AIDS Res Hum Retroviruses (1996) 1.46
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J Infect Dis (1977) 1.44
The current distribution of CD4+ T-lymphocyte counts among adults in the United States with human immunodeficiency virus infections: estimates based on the experience of the U.S. Army. U.S. Army Retrovirus Research Group. J Acquir Immune Defic Syndr (1990) 1.42
Suboccipital microsurgical removal of acoustic neurinomas of all sizes. Ann Otol Rhinol Laryngol (1973) 1.39
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines. J Immunol (1995) 1.37
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A (1991) 1.37
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37
Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J Clin Microbiol (1987) 1.33
Induction of interleukin-6 during human immunodeficiency virus infection. Blood (1990) 1.32
Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples. Ann Intern Med (1987) 1.32
Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine (1993) 1.32
Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg (1985) 1.30
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol (1995) 1.30
Rapid serodiagnosis of leptospirosis using the IgM-specific Dot-ELISA: comparison with the microscopic agglutination test. Am J Trop Med Hyg (1985) 1.28
Human immunodeficiency virus seropositivity among members of the active duty US Army 1985-89. Am J Public Health (1990) 1.26
HIV infection: the clinical picture. Sci Am (1988) 1.24
Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis (1996) 1.22
Febrile illness in Malaysia--an analysis of 1,629 hospitalized patients. Am J Trop Med Hyg (1984) 1.21
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology (2001) 1.20
Prevention of lower extremity stress fractures: a controlled trial of a shock absorbent insole. Am J Public Health (1988) 1.19
Building-associated risk of febrile acute respiratory diseases in Army trainees. JAMA (1988) 1.18
Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. J Immunol (1990) 1.18
Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1. J Acquir Immune Defic Syndr (1992) 1.16
An outbreak of spotted fever rickettsiosis in U.S. Army troops deployed to Botswana. Emerg Infect Dis (1996) 1.16
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J Virol (1997) 1.14
Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol (1996) 1.14
Cardiac risk factors and complications in non-cardiac surgery. Medicine (Baltimore) (1978) 1.10
Comparative mortality among US military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. JAMA (1996) 1.09
Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08
Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. N Engl J Med (1989) 1.08
Correlates of HIV-1 seropositivity among young men in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.07
Field trial of a Japanese encephalitis diagnostic kit. J Med Virol (1986) 1.05
A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J Virol (1994) 1.05
Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses (1993) 1.05
Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med (1977) 1.04
Human immunodeficiency virus type-1 seroconversion trends among young adults serving in the United States Army, 1985-1993. United States Military Medical Consortium for Applied Retroviral Research. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.04
The effect of halothane on electron transport, oxidative phosphorylation, and swelling in rat liver mitochondria. Mol Pharmacol (1970) 1.03
Age-specific prevalence of antibody to rotavirus, Escherichia coli heat-labile enterotoxin, Norwalk virus, and hepatitis A virus in a rural community in Thailand. J Clin Microbiol (1983) 1.02
The dependence of impulse propagation speed on firing frequency, dispersion, for the Hodgkin-Huxley model. Biophys J (1981) 1.01
Epidemic streptococcal disease among Army trainees, July 1989 through June 1991. J Infect Dis (1995) 1.00
Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission. Am J Trop Med Hyg (1992) 0.99
Trends of HIV seroconversion among young adults in the US Army, 1985 to 1989. US Army Retrovirus Research Group. JAMA (1991) 0.99